254723124	254723124	CD	B-NP	O
|	|	NN	I-NP	O
NMC	NMC	NN	I-NP	O
|	|	NN	I-NP	O
02022883	02022883	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1885239	1885239	CD	B-NP	O
|	|	CC	I-NP	O
2/28/2004	2/28/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NSTEMI	NSTEMI	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/28/2004	2/28/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/22/2004	9/22/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
CAPPO	CAPPO	NN	B-NP	B-protein
,	,	,	O	O
CARMELO	CARMELO	NN	B-NP	O
399-30-62-7	399-30-62-7	CD	I-NP	O
Rillmong	Rillmong	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
BHAMC	BHAMC	NNP	B-NP	B-cell_type
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/22/04	10/22/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FENISON	FENISON	NNP	B-NP	O
,	,	,	O	O
RAFAEL	RAFAEL	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NITROGLYCERIN	NITROGLYCERIN	NNP	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	O	O
0.4	0.4	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-DNA
SL	SL	NN	I-NP	I-DNA
Q5MIN	Q5MIN	NN	I-NP	I-DNA
X	X	NN	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
administer	administer	VB	I-VP	O
if	if	IN	B-SBAR	O
receiving	receive	VBG	B-VP	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

PREDNISONE	PREDNISONE	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QAM	QAM	NN	I-NP	I-protein
TRAZODONE	TRAZODONE	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
HS	HS	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Insomnia	Insomnia	NNP	I-NP	I-protein
ZOLOFT	ZOLOFT	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
SERTRALINE	SERTRALINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ZOCOR	ZOCOR	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/7	3/7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

PLAVIX	PLAVIX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Begin	Begin	NNP	B-NP	O
Plavix	Plavix	NNP	I-NP	O
tomorrow	tomorrow	NN	B-NP	O
if	if	IN	B-SBAR	O
a	a	DT	B-NP	O
loading	loading	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

ADVAIR	ADVAIR	NN	B-NP	O
DISKUS	DISKUS	VBZ	B-VP	O
250/50	250/50	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-DNA
-RRB-	-RRB-	SYM	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
PUFF	PUFF	NN	I-NP	I-DNA
INH	INH	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
DILTIAZEM	DILTIAZEM	NNP	I-NP	I-DNA
CD	CD	NNP	I-NP	I-DNA
120	120	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Alliance	Alliance	NNP	I-NP	O
2-4	2-4	CD	I-NP	O
weeks	week	NNS	I-NP	O
-LRB-	-LRB-	IN	B-SBAR	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
a	a	DT	B-NP	O
phone	phone	NN	I-NP	O
call	call	NN	I-NP	O
with	with	IN	B-PP	O
time	time	NN	B-NP	O
from	from	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Langanke	Langanke	NNP	I-NP	O
office	office	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Primary	Primary	JJ	B-NP	B-protein
care	care	NN	I-NP	I-protein
physician	physician	NN	I-NP	I-protein
1-2	1-2	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
NSTEMI	NSTEMI	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NSTEMI	NSTEMI	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
OBESITY	OBESITY	NNP	I-NP	O
RAD	RAD	NNP	I-NP	O
MULT	MULT	NNP	I-NP	O
TAPERS	TAPERS	NNP	I-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
OSA	OSA	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
sleep	sleep	NN	I-NP	I-protein
apnea	apnea	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
?	?	.	O	O

diabetes	diabetes	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
?	?	.	O	O

diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiac	Cardiac	NNP	I-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
45yoF	45yoF	NN	B-NP	O
with	with	IN	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
p/w	p/w	NN	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
while	while	IN	B-SBAR	O
teaching	teach	VBG	B-VP	O
class	class	NN	B-NP	O
today	today	NN	B-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
assoc	assoc	NN	B-NP	O
with	with	IN	B-PP	O
sob	sob	NN	B-NP	B-protein
and	and	CC	I-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
ED	ED	JJ	B-NP	B-protein
obs	ob	NNS	I-NP	I-protein
,	,	,	O	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
tni	tni	NNS	B-NP	O
on	on	IN	B-PP	O
b	b	NN	B-NP	O
set	set	NN	I-NP	O
=	=	SYM	B-VP	O
2	2	CD	B-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
reportedly	reportedly	RB	B-ADVP	O
without	without	IN	B-PP	O
change	change	NN	B-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
have	have	VBP	B-VP	O
twi	twi	NNS	B-NP	O
in	in	IN	B-PP	O
precordial	precordial	JJ	B-NP	O
leads	lead	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
developed	develop	VBD	B-VP	O
renewed	renew	VBN	I-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
floor	floor	NN	B-NP	O
assoc	assoc	NN	I-NP	O
with	with	IN	B-PP	O
n/v	n/v	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
emergent	emergent	JJ	B-NP	O
cath	cath	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
lad	lad	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
with	with	IN	B-PP	O
drug-eluting	drug-eluting	JJ	B-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
HOSP	HOSP	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYTEMS	SYTEMS	NN	I-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
isch-s/p	isch-s/p	NN	B-NP	O
stenting	stente	VBG	B-VP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
for	for	IN	B-PP	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
cont	cont	NN	I-NP	O
asa	asa	NN	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
-	-	HYPH	B-VP	O
held	hold	VBN	B-NP	O
hctz	hctz	NN	I-NP	O
but	but	CC	O	O
instructed	instruct	VBD	B-VP	O
pt	pt	NN	B-NP	O
to	to	TO	B-VP	O
re-start	re-start	VB	I-VP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
initially	initially	RB	I-NP	O
tx	tx	NN	I-NP	O
pt	pt	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
bb	bb	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
exacerbate	exacerbate	VB	I-VP	O
her	her	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
so	so	RB	B-NP	O
this	this	DT	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	I-VP	O
diltiazem	diltiazem	VB	I-VP	O
.	.	.	O	O

Norvasc	Norvasc	NN	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
-	-	HYPH	B-NP	O
pt	pt	NN	I-NP	B-protein
received	receive	VBD	B-VP	I-protein
integrilin	integrilin	NN	B-NP	I-protein
x	x	SYM	B-NP	O
18h	18h	NN	I-NP	O
post	post	NN	I-NP	O
cath	cath	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
asthma	asthma	NN	B-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
for	for	IN	B-PP	O
recent	recent	JJ	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
taper	taper	VB	I-VP	O
after	after	IN	B-PP	O
d/c	d/c	NN	B-NP	O
-	-	HYPH	B-NP	O
cont	cont	NN	I-NP	O
inhalers	inhaler	NNS	I-NP	O
3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Psych	Psych	NN	I-NP	O
:	:	:	O	O
cont	cont	VB	B-VP	O
zoloft	zoloft	NN	B-NP	O
,	,	,	O	O
ativan	ativan	IN	B-ADVP	O
Pt	Pt	NNP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
pcp	pcp	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
have	have	VBP	B-VP	O
new	new	JJ	B-NP	O
medicines	medicine	NNS	I-NP	O
:	:	:	O	O
diltiazem	diltiazem	NN	B-NP	O
SR	SR	NN	I-NP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	O
hydrochlorothiazide	hydrochlorothiazide	NN	I-NP	O
.	.	.	O	O

Stop	Stop	NN	B-NP	O
taking	take	VBG	B-VP	O
norvasc	norvasc	NN	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
needed	need	VBN	B-NP	O
take	take	NN	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
tablets	tablet	NNS	I-NP	O
under	under	IN	B-PP	O
your	your	PRP$	B-NP	O
tongue	tongue	NN	I-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
follow	follow	VBP	B-VP	O
directions	direction	NNS	B-NP	O
on	on	IN	B-PP	O
prescription	prescription	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pains	pain	NNS	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
please	please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
come	come	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

Taper	Taper	VB	B-VP	O
your	your	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
on	on	IN	B-PP	O
prescription	prescription	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
and	and	CC	O	O
discuss	discuss	VB	B-VP	O
this	this	DT	B-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Domke	Domke	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
in	in	IN	B-PP	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TREVOR	TREVOR	NNP	B-NP	O
,	,	,	O	O
RUSS	RUSS	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FW96	FW96	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/22/04	10/22/04	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
33	33	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

